Royalty Pharma plc - Class A Ordinary Shares (RPRX) earnings
RPRX earnings moved a median of +0.17% by the close. Quarterly and annual RPRX reports and results, each read against the price at its own news timestamp. Back to the RPRX overview →
39 measured RPRX earnings events.
Where these RPRX earnings landedvs 39 measured RPRX earnings reactions
| Middle 50% of RPRX earnings reactions | -1.30% to +1.63% |
|---|---|
| Median reaction (to close) | +0.17% |
| Measured reactions | 39 |
Point-in-time · zero look-ahead
Half of the 39 RPRX earnings events with a measured close landed between -1.30% and +1.63%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Royalty Pharma declares fourth quarter 2026 dividend | Press release | -0.28% | +1.79% | |
| Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026 | Press release | +0.25% | +1.61% | |
| Form 10-Q Royalty Pharma plc For: Jun 30 | SEC filing · Form 10-Q | -1.10% | -2.99% | |
| Royalty Pharma reports second quarter 2026 results | Press release | -1.10% | -2.99% | |
| Royalty Pharma declares third quarter 2026 dividend | Press release | +0.58% | -1.79% | |
| Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026 | Press release | +0.32% | +3.28% | |
| Form 10-Q Royalty Pharma plc For: Mar 31 | SEC filing · Form 10-Q | -1.45% | -1.51% | |
| Royalty Pharma reports first quarter 2026 results | Press release | -1.45% | -1.51% | |
| Royalty Pharma Declares Second Quarter 2026 Dividend | Press release | +0.58% | +2.88% | |
| Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026 | Press release | +0.73% | -0.04% | |
| Form 10-K Royalty Pharma plc For: Dec 31 | SEC filing · Form 10-K | +0.65% | +3.05% | |
| Form 10-Q Royalty Pharma plc For: Sep 30 | SEC filing · Form 10-Q | +4.63% | +10.44% | |
| Royalty Pharma Reports Third Quarter 2025 Results | Press release | +4.63% | +10.44% | |
| Royalty Pharma Declares Fourth Quarter 2025 Dividend | Press release | +0.39% | +1.87% | |
| Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025 | Press release | -0.85% | -0.85% | |
| Form 10-Q Royalty Pharma plc For: Jun 30 | SEC filing · Form 10-Q | +1.36% | +0.16% | |
| Royalty Pharma Reports Second Quarter 2025 Results | Press release | +0.79% | +0.49% | |
| Royalty Pharma Declares Third Quarter 2025 Dividend | Press release | -0.23% | +0.03% | |
| Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025 | Press release | +0.17% | +0.17% | |
| Form 10-Q Royalty Pharma plc For: Mar 31 | SEC filing · Form 10-Q | +3.63% | +1.47% | |
| Royalty Pharma Reports First Quarter 2025 Results | Press release | +3.63% | +1.47% | |
| Royalty Pharma Declares Second Quarter 2025 Dividend | Press release | +0.01% | -1.17% | |
| Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025 | Press release | -0.49% | -1.44% | |
| Form 10-K Royalty Pharma plc For: Dec 31 | SEC filing · Form 10-K | -0.00% | +0.22% | |
| Form 10-Q Royalty Pharma plc For: Sep 30 | SEC filing · Form 10-Q | -0.18% | -5.30% | |
| Royalty Pharma Reports Third Quarter 2024 Results | Press release | -0.18% | -5.30% | |
| Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024 | Press release | -0.28% | -0.32% | |
| Royalty Pharma Declares Fourth Quarter 2024 Dividend | Press release | +0.62% | +1.89% | |
| Form 10-Q Royalty Pharma plc For: Jun 30 | SEC filing · Form 10-Q | -3.58% | -5.36% | |
| Royalty Pharma Reports Second Quarter 2024 Results | Press release | -3.58% | -5.36% | |
| Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024 | Press release | -0.21% | -0.32% | |
| Royalty Pharma Declares Third Quarter 2024 Dividend | Press release | -0.23% | +1.18% | |
| Form 10-Q Royalty Pharma plc For: Mar 31 | SEC filing · Form 10-Q | +1.27% | -0.92% | |
| Royalty Pharma Reports First Quarter 2024 Results | Press release | +1.27% | -0.92% | |
| Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024 | Press release | -0.18% | +1.11% | |
| Royalty Pharma Declares Second Quarter 2024 Dividend | Press release | +0.00% | +0.25% | |
| Form 10-K Royalty Pharma plc For: Dec 31 | SEC filing · Form 10-K | -0.14% | +1.21% | |
| Form 10-Q Royalty Pharma plc For: Sep 30 | SEC filing · Form 10-Q | +0.59% | +1.66% | |
| Royalty Pharma Reports Third Quarter 2023 Results | Press release | +0.59% | +1.66% |
Keep exploring
More RPRX: analyst actions → · SEC filings → · RPRX overview →